Clinical Trial Update: A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient [Phase 3]

View source ↗

Summary

Phase 3 trial comparing amlodipine 10 mg versus 5 mg in hypertension where 5 mg is insufficient; completed with posted results in 2008.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2008-12-09